Probity Advisors’s Clorox CLX Stock Holding History

Probity Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$514K	Buy	4,962 +1,303	+36%	+$148K	0.08%	153
2025 Q4	$369K	Buy	+3,659	New	+$397K	0.06%	183

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Probity Advisors's CLX Position: Q1 2026 in Review

Probity Advisors increased its Clorox (CLX) stake by 36% in Q1 2026, buying an estimated $148K and bringing the position to 4,962 shares worth $514K. The position accounts for 0.08% of the portfolio, ranked #153.

Probity Advisors first reported a position in CLX in Q4 2025 and has held it in 2 quarters since. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Probity Advisors held 4,962 shares of Clorox worth $514K as of Q1 2026.
Probity Advisors bought 1,303 Clorox shares in Q1 2026, an estimated $148K.
Clorox made up 0.08% of Probity Advisors's portfolio in Q1 2026, its #153 holding.
Probity Advisors first reported a position in Clorox in Q4 2025 and has held it in 2 quarters since.
1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Probity Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.